576 related articles for article (PubMed ID: 25556047)
1. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
[TBL] [Abstract][Full Text] [Related]
2. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
Zhao S; Musa SS; Qin J; He D
Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
[TBL] [Abstract][Full Text] [Related]
3. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.
Averbuch D; Hidalgo-Grass C; Moses AE; Engelhard D; Nir-Paz R
Emerg Infect Dis; 2011 Jun; 17(6):1079-82. PubMed ID: 21749775
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
5. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
7. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
8. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.
Hsieh YC; Tsao KC; Huang CG; Tong S; Winchell JM; Huang YC; Shia SH; Lai SH; Lin TY
Pediatr Infect Dis J; 2012 Feb; 31(2):208-9. PubMed ID: 21941216
[TBL] [Abstract][Full Text] [Related]
10. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
12. Macrolide-Resistant Mycoplasma pneumoniae, United States.
Zheng X; Lee S; Selvarangan R; Qin X; Tang YW; Stiles J; Hong T; Todd K; Ratliff AE; Crabb DM; Xiao L; Atkinson TP; Waites KB
Emerg Infect Dis; 2015 Aug; 21(8):1470-2. PubMed ID: 26196107
[TBL] [Abstract][Full Text] [Related]
13. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
[TBL] [Abstract][Full Text] [Related]
14. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
[No Abstract] [Full Text] [Related]
15. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
[TBL] [Abstract][Full Text] [Related]
16. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.
Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S
J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728
[TBL] [Abstract][Full Text] [Related]
17. [Servere atypical pneumonia with macrolide-resistant Mycoplasma pneumoniae].
Bruno Pedersen AS; Østergaard L; Jespersen S
Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037385
[TBL] [Abstract][Full Text] [Related]
18. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.
Chironna M; Sallustio A; Esposito S; Perulli M; Chinellato I; Di Bari C; Quarto M; Cardinale F
J Antimicrob Chemother; 2011 Apr; 66(4):734-7. PubMed ID: 21393214
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Lee H; Yun KW; Lee HJ; Choi EH
Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
[TBL] [Abstract][Full Text] [Related]
20. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
Chen YC; Hsu WY; Chang TH
Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
